KADMON HOLDINGS

 KDMNのチャート


 KDMNの企業情報

symbol KDMN
会社名 Kadmon Holdings Inc (KADMON HOLDINGS)
分野(sector)   
産業(industry)   
業種 医薬品   医療関連(Health Care)
概要 カドモン・ホールディングス(Kadmon Holdings Inc)(旧名: Kadmon Holdings LLC)は小分子・バイオ製剤の発見・開発・商業化に従事するバイオ医薬品会社である。同社は自己免疫・繊維性・腫瘍・遺伝性疾患の治療向けの候補製品を開発する。同社は腫瘍治療のKD025とTesevatinib、多発性嚢胞腎(PKD)治療のTesevatinib及びKD034を含む。同社はRibasphere RibaPak、Ribasphereタブレット、Ribasphere、Qsymia、Tetrabenazine及びValganciclovirを含む錠剤・カプセルを提供する。KD025は経口選択的ROCK2 阻害剤であるrhoキナーゼ2プラットフォームにおける候補製品である。Tesevatinibは腫瘍増殖・転移・薬物耐性のドライバー分子を阻害する経口チロシン・キナーゼ阻害薬(TKI)である。KD034は体内の過剰銅を除去するキレート化合物である塩酸トリエンチン製剤のウィルソン病治療のポートフォリオである。  カドモン・ホ―ルディングスは米国のバイオ医薬品持株会社。子会社を通じ、バイオ製剤の開発・商業化に従事する。自己免疫機能を取り入れ、線維性疾患、がん、遺伝病などの治療向けに小分子やバイオ製剤を開発。同社の候補薬には多発性嚢胞腎治療の「KD034」と「Tesevatinib」などがある。本社はニューヨーク。  
本社所在地 450 East 29th Street New York NY 10016 USA
代表者氏名 Tasos G. Konidaris
代表者役職名 Interim Chairman of the Board
電話番号 +1 212-308-6000
設立年月日 40422
市場名 NYSE(ニューヨーク証券取引所)
ipoyear
従業員数 116人
url www.kadmon.com
nasdaq_url
adr_tso
EBITDA (百万ドル) -84.31500
終値(lastsale)
時価総額(marketcap)
時価総額 (百万ドル) 368.03760
売上高 (百万ドル) 1.39600
企業価値(EV) (百万ドル) 343.00860
当期純利益 (百万ドル) -56.86300
決算概要 BRIEF: For the fiscal year ended 31 December 2018 Kadmon Holdings Inc revenues decreased 89% to $1.4M. Net loss applicable to common stockholders excluding extraordinary items decreased 31% to $56.9M. Revenues reflect License and other revenue decrease of 90% to $705K Net sales decrease of 87% to $691K. Lower net loss reflects Loss on equity method investment decrease of 84% to $1.2M (expense).

 KDMNのテクニカル分析


 KDMNのニュース

   FDA delays Kadmon’s priority review as apparent clampdown continues  2021/03/11 13:18:18 Endpoints News
Kadmon Holdings just lost their priority review. The immunology biotech announced Wednesday that the FDA has pushed back the decision date for their graft-versus-host disease drug belumosudil by three months, after the agency requested additional information from the drugmaker. That will effectively turn their 6-month priority review into a 9-month
   Kadmon Announces U.S. FDA Has Extended the Review Period for Belumosudil in Chronic Graft-Versus-Host Disease  2021/03/10 21:14:00 Yahoo Finance
NEW YORK, NY / ACCESSWIRE / March 10, 2021 / Kadmon Holdings, Inc. (NASDAQ:KDMN) today announced that the U.
   FXNEWS24 |Kadmon Holdings, Inc. (KDMN) Reviews This autumn Loss, Tops Income Estimates | UK Forex Reviews  2021/03/05 05:35:52 FXNews24
Kadmon Holdings, Inc. (KDMN) Reviews This autumn Loss, Tops Income Estimates | UK Stocks, Forex, Commodities, Crypto, Live Market News- Daily Forex News
   Kadmon Announces Proposed $150 Million Convertible Senior Notes Offering with Capped Call Transactions  2021/02/10 21:01:00 Yahoo Finance
NEW YORK, NY / ACCESSWIRE / February 10, 2021 / Kadmon Holdings, Inc. (NASDAQ:KDMN) today announced its intent to offer, subject to market conditions and other factors, $150 million aggregate principal amount of convertible senior notes due 2027 (the "Notes") in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.
   Kadmon Holdings (KDMN) Receives a Buy from Oppenheimer  2020/12/01 14:08:06 Smarter Analyst
In a report issued on December 10, Mark Breidenbach from Oppenheimer maintained a Buy rating on Kadmon Holdings (KDMN), with a price target of $8.00. The
   Kadmon Holdings (KDMN) Receives a Buy from Oppenheimer  2020/12/01 14:08:06 Smarter Analyst
In a report issued on December 10, Mark Breidenbach from Oppenheimer maintained a Buy rating on Kadmon Holdings (KDMN), with a price target of $8.00. The
   Kadmon to Host Virtual Key Opinion Leader Event at the 62nd ASH Annual Meeting  2020/11/24 13:00:00 Yahoo Finance
NEW YORK, NY / ACCESSWIRE / November 24, 2020 / Kadmon Holdings, Inc.
   Kadmon (NYSE:KDMN) Shares Down 7.8%  2020/10/21 19:58:44 The Olympia Report
Shares of Kadmon Holdings Inc (NYSE:KDMN) traded down 7.8% on Wednesday . The company traded as low as $3.41 and last traded at $3.42. 2,904,642 shares traded hands during mid-day trading, an increase of 26% from the average session volume of 2,301,143 shares. The stock had previously closed at $3.71. A number of research analysts […]
   Kadmon Holdings Inc (NYSE:KDMN) Expected to Post Quarterly Sales of $530,000.00  2020/10/21 10:54:41 Stock Observer
Brokerages expect Kadmon Holdings Inc (NYSE:KDMN) to announce sales of $530,000.00 for the current fiscal quarter, Zacks Investment Research reports. Four analysts have provided estimates for Kadmon’s earnings, with the lowest sales estimate coming in at $230,000.00 and the highest estimate coming in at $960,000.00. Kadmon posted sales of $230,000.00 in the same quarter last […]
   Kadmon Holdings (KDMN) Investor Presentation - Slideshow (NYSE:KDMN)  2020/09/17 18:26:04 Seeking Alpha
The following slide deck was published by Kadmon Holdings, Inc. in conjunction with this event..
   Kadmon Holdings (KDMN) Receives a Buy from Oppenheimer  2020/12/01 14:08:06 Smarter Analyst
In a report issued on December 10, Mark Breidenbach from Oppenheimer maintained a Buy rating on Kadmon Holdings (KDMN), with a price target of $8.00. The
   Kadmon to Host Virtual Key Opinion Leader Event at the 62nd ASH Annual Meeting  2020/11/24 13:00:00 Yahoo Finance
NEW YORK, NY / ACCESSWIRE / November 24, 2020 / Kadmon Holdings, Inc.
   Kadmon (NYSE:KDMN) Shares Down 7.8%  2020/10/21 19:58:44 The Olympia Report
Shares of Kadmon Holdings Inc (NYSE:KDMN) traded down 7.8% on Wednesday . The company traded as low as $3.41 and last traded at $3.42. 2,904,642 shares traded hands during mid-day trading, an increase of 26% from the average session volume of 2,301,143 shares. The stock had previously closed at $3.71. A number of research analysts […]
   Kadmon Holdings Inc (NYSE:KDMN) Expected to Post Quarterly Sales of $530,000.00  2020/10/21 10:54:41 Stock Observer
Brokerages expect Kadmon Holdings Inc (NYSE:KDMN) to announce sales of $530,000.00 for the current fiscal quarter, Zacks Investment Research reports. Four analysts have provided estimates for Kadmon’s earnings, with the lowest sales estimate coming in at $230,000.00 and the highest estimate coming in at $960,000.00. Kadmon posted sales of $230,000.00 in the same quarter last […]
   Kadmon Holdings (KDMN) Investor Presentation - Slideshow (NYSE:KDMN)  2020/09/17 18:26:04 Seeking Alpha
The following slide deck was published by Kadmon Holdings, Inc. in conjunction with this event..

 関連キーワード  (医薬品 米国株 KADMON HOLDINGS KDMN )

 twitter  (公式ツイッターやCEOツイッターなど)